SILICON VALLEY, Calif., Feb. 18, 2016 /PRNewswire/ -- Bay Area Lyme Foundation, a leading nonprofit funder of innovative Lyme disease research in the US, today announced that the Foundation is the first to offer free tick testing for residents of the U.S. Testing is available through a partnership with Nate Nieto, PhD, Assistant Professor, Department of Biological Sciences, Northern Arizona University and his lab. Bay Area Lyme Foundation hopes to use this crowd-sourced data as a vehicle for gaining a greater understanding of the geography of tick-borne diseases in the U.S. If successful in accumulating data, it will be the first crowd-sourced study of its kind.
"A major challenge for the Lyme disease community is understanding the prevalence of Lyme disease bacteria in ticks throughout the U.S., so that physicians and residents can be appropriately vigilant to the symptoms of the disease," explained Laure Woods, President and Co-founder, Bay Area Lyme Foundation, who conceptualized this idea, and provided funding to Bay Area Lyme Foundation through a grant from the Laurel Foundation to cover the initial costs of the tick analyses.
"With this effort, we intend to make it easier for people who have been bit by ticks, particularly in geographic areas where Lyme disease is not yet recognized as endemic, to understand their potential risk," added Woods.
This free service is designed to offer insights into the pathogens carried by ticks, and the results, in addition to any symptoms, should be discussed with a healthcare provider. Results from the tick test are not meant to be a diagnostic and individuals should discuss any symptoms or changes in health status with their physicians, as some tick bites will not transmit agents that cause disease.
"This new initiative has the potential to gather extensive data on the geographic distribution and future expansion of ticks carrying pathogens that causes various diseases in humans, and could allow us the opportunity to better understand where in the U.S. we are at a greater risk of acquiring these diseases," stated Dr. Nieto, who cited climate change among other reasons the risk of acquiring Lyme exists in areas outside the known endemic Northeast.
Northern Arizona University will accept ticks from any state in the U.S. Ticks will be tested for 6 bacterial infections: Borrelia burgdorferi, which causes Lyme disease; Borrelia miyamotoi, which causes tick-borne relapsing fever; Anaplasma phagocytophilum, which causes human granulocytic anaplasmosis, Ehrlichia chafeensis, which causes human monocytic erhlichiosis, and Rickettsia rickettsii, the agent of Rocky-mountain spotted fever, and the protozoan pathogen, Babesia microti. Results will be available within five business days of receipt based on estimated volumes, and the data will be reported to the sender by email, as well as mapped, categorized and recorded.
There is a great misconception that Lyme is easy to diagnose due to the bull's eye rash. However, the rash (Erythema migrans) only occurs in approximately 70-80% of infected persons and only a subset of erythema migrans rashes resemble a bull's eyei. In fact, the current "gold standard" diagnostic for Lyme disease misses up to 60% of cases of early stage Lyme diseaseii. Therefore, knowing the general symptoms of the first stage of Lyme disease (and other tick-borne pathogens) is critical in reducing the burden of disease in people. Typical symptoms include headaches, flu-like illness, joint pain, fatigue, and sometimes a rash that has a few different shapes including one which may look like a bull's eye centered on the tick bite.
U.S. residents seeking more information should visit: http://www.bayarealyme.org/lyme-disease-prevention/tick-testing/
About Lyme disease
One of the fastest growing vector-borne infectious diseases in the United States, Lyme disease is a potentially debilitating infection caused by bacteria transmitted through the bite of an infected tick to people and pets. If caught early, most cases of Lyme disease can be effectively treated, but it is commonly misdiagnosed due to lack of awareness and unreliable diagnostic tests. There are approximately 329,000 new cases of Lyme disease each year, according to statistics released in 2015 by the CDC. As a result of the difficulty in diagnosing and treating Lyme disease, as many as one million Americans may be suffering from the impact of its debilitating long-term symptoms and complications, according to Bay Area Lyme Foundation estimates.
About Bay Area Lyme Foundation
Bay Area Lyme Foundation, a national nonprofit organization committed to making Lyme disease easy to diagnose and simple to cure, is a leading private sponsor of innovative Lyme disease research in the US. A national 501c3 nonprofit organization based in Silicon Valley, the Foundation collaborates with world-class scientists and institutions to accelerate medical breakthroughs for Lyme disease. It is also dedicated to providing reliable, fact-based information so that prevention and the importance of early treatment are common knowledge. A pivotal donation from The Laurel Foundation covers all overhead costs and allows for 100% of all donor contributions to Bay Area Lyme Foundation to go directly to research programs. For more information about Lyme disease or to get involved, visit www.bayarealyme.org or call us at 650-530-2439.
i Correspondence. The Presenting Manifestations of Lyme Disease and the Outcomes of Treatment. N Engl J Med 2003; 348:2472-2474, June 12, 2003
ii Rosenfeld , Wang, Schwartz, Wormser, 2005
SOURCE Bay Area Lyme Foundation